Free stomach infection test and treatment could prevent cancer in at-risk communities

NCT ID NCT07224035

Ongoing Prevention Sponsor: University of Miami Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study screens 500 adults in South Florida for H. pylori, a stomach infection that can lead to chronic gastritis, ulcers, and gastric cancer. Those who test positive receive free treatment with a three-drug combination (VOQUEZNA® Triple Pak®) for 14 days. The goal is to see if screening and early treatment can prevent serious stomach diseases.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: VOQUEZNA® Triple Pak® (vonoprazan, amoxicillin, clarithromycin) and PYtest® 14C-Urea Breath Test
What this could lead to: If successful, this could show that widespread screening and treatment of H. pylori reduces the risk of stomach cancer and other complications in high-risk communities.
What could go wrong: This is a single-site study with 500 participants, so results may not apply to all populations. The treatment requires a 14-day course of antibiotics, which can cause side effects like diarrhea or allergic reactions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

gastric neoplasm Helicobacter pylori infectious disease gastric cancer prevention target gastritis prevention target peptic ulcer disease prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

GASTRIC CANCER H PYLORI GASTRITIS H.PYLORI INFECTION

Contacts and locations

Locations

University of Miami

Miami, Florida, 33136, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.